New perspectives on the ligands and function of the killer cell immunoglobulin-like receptor KIR3DL2 in health and disease

Frontiers in Immunology

Volumn 3, Issue NOV, 2012, Pages

  Shaw, Jacqueline ^a   Kollnberger, Simon ^a  

^a UNIVERSITY OF OXFORD   (United Kingdom)

Author keywords

Ankylosing spondylitis; B272; CpG DNA; HLA A11; HLA A3; HLA B27; KIR3DL2; S zary's syndrome

Indexed keywords

EID: 84874214290     PISSN: None     EISSN: 16643224     Source Type: Journal    
DOI: 10.3389/fimmu.2012.00339     Document Type: Review

References (51)

1. Bird, L.A., Peh, C.A., Kollnberger, S., Elliott, T., McMichael, A.J., and Bow-ness, P. (2003). Lymphoblastoid cells express HLA-B27 homodimers both intracellularly and at the cell surface following endosomal recycling. Eur. J. Immunol. 33,748-759.
2. Bowness, P., Ridley, A., Shaw, J., Chan, A., Wong Baeza, I., Fleming, M., et al. (2011). Th17 cells expressing KIR3DL2+ and responsive to HLA- B27 homodimers are increased in Ankylosing Spondylitis. J. Immunol. 186,2672-2680.
3. Brando, C., Mukhopadhyay, S., Kovacs, E., Medina, R., Patel, P., Catina, T. L., et al. (2005). Receptors and lytic mediators regulatinganti-tumor activity by the leukemic killer T cell line TALL-104. J. Leukoc. Biol. 78, 359-371.
4. Brown, M. A. (2011). Progress in the genetics of ankylosing spondyli- tis. Brief. Funct. Genomics 10, 249-257.
5. Brown, M. A., Pile, K. D., Kennedy, L. G., Calin, A., Darke, C., Bell, J., et al. (1996). HLA class I associations of ankylosing spondylitis in the white population in the United Kingdom. Ann. Rheum. Dis. 55,268-270.
6. Cauli, A., Dessole, G., Nurchis, P. P., Vacca, A., Mameli, A., Garau, P., et al. (2002). The role of HLA- B27 molecules in the pathogenesis of ankylosing spondylitis. Reumatismo 54,266-271.
7. Chan, A. T., Kollnberger, S. D., Wed-derburn, L. R., and Bowness, P. Shaw and Kollnberger HLA class 1 and innate ligands of KIR3DL2 (2005).Expansion and enhanced sur- vival of natural killer cells express- ing the killer immunoglobulin-like receptor KIR3DL2 in spondylarthri- tis. Arthritis Rheum. 52,3586-3595
8. Chan, A., Filer, A., Parsonage, G., Kollnberger, S., Gundle, R., Buckley, C. D., et al. (2008). Mediation of the proinflammatory cytokine response in rheumatoid arthritis and spondy- larthritis by interactions between fibroblast-like synoviocytes and nat- ural killer cells. Arthritis Rheum. 58, 707-717.
9. Chan, H. W., Kurago, Z. B., Stewart, C. A., Wilson, M. J., Martin, M. P., Mace, B. E., et al. (2003). DNA methylation maintains allele-specific KIR gene expression in human nat- ural killer cells. J. Exp. Med. 197, 245-255.
10. Ciccia, F., Bombardieri, M., Principato, A., Giardina,A., Tripodo, C., Porcasi, R., et al. (2009). Overexpression of interleukin-23, but not interleukin- 17, as an immunologic signature of subclinical intestinal inflammation in ankylosing spondylitis. Arthritis Rheum. 60,955-965.
11. Cichocki, F., Hanson, R. J., Lenvik, T., Pitt, M., McCullar, V., Li, H., et al. (2009). The transcription factor c-Myc enhances KIR gene transcrip- tion through direct binding to an upstream distal promoter element. Blood 113, 3245-3253.
12. Ciree, A., Michel, L., Camilleri-Broet, S., Jean Louis, F., Oster, M., Flageul, B., et al. (2004). Expression and activity of IL-17 in cutaneous T-cell lymphomas (mycosis fungoides and Sezary syndrome). Int. J. Cancer 112, 113-120.
13. Colonna, M., and Samaridis, J. (1995).Cloningof immunoglobulin- superfamily members associatedwith HLA-C and HLA-B recognition by human natural killer cells. Science 268, 405-408.
14. Dohring,C.,Scheidegger,D.,Samaridis, J.,Cella,M.,andColonna,M.(1996). A human killer inhibitory receptor specific for HLA-A1,2. J. Immunol. 156, 3098-3101.
15. Fadda, L., Borhis, G., Ahmed, P., Cheent, K., Pageon, S. V., Cazaly, A., et al. (2010). Peptide antagonism as a mechanism for NK cell activa- tion. Proc. Natl. Acad. Sci. U.S.A. 107, 10160-10165.
16. Fauriat, C., Andersson, S., Bjorklund, A. T., Carlsten, M., Schaffer, M., Bjorkstrom, N. K., et al. (2008). Esti- mation of the size of the alloreactive NK cell repertoire: studies in indi- viduals homozygous for the group A KIR haplotype. J. Immunol. 181, 6010-6019.
17. Fauriat, C., Long, E. O., Ljunggren, H. G., and Bryceson, Y. T. (2010). Reg- ulation of human NK-cell cytokine and chemokine production by target cell recognition. Blood 115, 2167- 2176.
18. Giles, J., Shaw, J., Piper, C., Wong-Baeza, I., McHugh, K., Ridley, A., et al. (2012). HLA-B27 homodimers and free heavy chains are stronger lig- ands for LILRB2 than classical HLA class 1. J. Immunol. 188,6184-6193.
19. Graef, T., Moesta, A. K., Norman, P. J., Abi-Rached, L., Vago, L., Older Aguilar,A.M.,et al.(2009).KIR2DS4 is a product of gene conversion with KIR3DL2 that introduced speci- ficity for HLA-A*11 while diminish- ing avidity for HLA-C. J. Exp. Med. 206,2557-2572.
20. Hansasuta,P.,Dong,T.,Thananchai,H., Weekes, M., Willberg, C., Aldemir, H.,et al.(2004). RecognitionofHLA- A3 and HLA-A11 by KIR3DL2 is peptide-specific. Eur. J. Immunol. 34, 1673-1679.
21. Harvey, D., Pointon, J. J., Sleator, C., Meenagh, A., Farrar, C., Sun, J. Y., et al. (2009). Analysis of killer immunoglobulin-like receptor genes in ankylosing spondylitis. Ann. Rheum. Dis. 68,595-598.
22. Jovanovic, D. V., Di Battista, J. A., Martel-Pelletier, J., Jolicoeur, F. C., He, Y., Zhang, M., et al. (1998). IL-17 stimulates the production and expression of proinflammatory cytokines, IL-beta and TNF-alpha, by human macrophages. J. Immunol. 160,3513-3521.
23. Kollnberger, S., Bird, L., Sun, M. Y., Retiere, C., Braud,V. M., McMichael, A., et al. (2002). Cell-surface expres- sion and immune receptor recog- nition of HLA-B27 homodimers. Arthritis Rheum. 46,2972-2982.
24. Kollnberger, S., Chan, A., Sun, M. Y., Chen, L. Y., Wright, C., di Gleria, K., et al. (2007). Interaction of HLA- B27 homodimers with KIR3DL1 and KIR3DL2, unlike HLA-B27 het- erotrimers, is independent of the sequence of bound peptide. Eur. J. Immunol. 37, 1313-1322.
25. Laan, M., Cui, Z. H., Hoshino, H., Lot-vall, J., Sjostrand, M., Gruenert, D. C., et al. (1999). Neutrophil recruit- ment by human IL-17 via C-X-C chemokine release in the airways. J. Immunol. 162,2347-2352.
26. Lan, C. E., Tsai, W. C., Wu, C. S., Lu, C. L., and Yu, H. S. (2004). Psori- atic patients with arthropathy show significant expression of free HLA class I heavy chains on circulating monocytes: a potential role in the pathogenesis of psoriatic arthritis.Br. J. Dermatol. 151,24-31.
27. Marcenaro, E., Carlomagno, S., Pesce, S., Moretta, A., and Sivori, S. (2011). Bridging innate NK cell functions with adaptive immunity. Adv. Exp. Med. Biol. 780,45-55.
28. Marsh, S. G., Parham, P., Dupont, B., Geraghty, D. E., Trowsdale, J., Mid-dleton, D., et al. (2003). Killer-cell immunoglobulin-like receptor (KIR) nomenclature report,2002.Immuno- genetics 55, 220-226.
29. Mills,K. H. (2008). Induction,function and regulation of IL-17-producing T cells. Eur. J. Immunol. 38, 2636- 2649.
30. Musette, P., Michel, L., Jean-Louis, F., Bagot, M., and Bensussan, A. (2003). Polymorphic expression of CD158k/p140/KIR3DL2 in Sezary patients. Blood 101, 1203.
31. Obama, K., Kubota, R., Tara, M., Furukawa, Y., Osame, M., and Arimura, K. (2007). Killer cell immunoglobulin-like receptor/3DL2 expression in adult T-cell leukaemia. Br. J. Haematol. 138, 666-667.
32. Ortonne, N., Huet, D., Gaudez, C., Marie-Cardine, A., Schiavon, V., Bagot, M., et al. (2006). Significance of circulating T-cell clones in Sézary syndrome. Blood 107,4030-4038.
33. Payeli, S. K., Kollnberger, S., Mar-roquin Belaunzaran, O., Thiel, M., McHugh, K., Giles, J., et al. (2012). Inhibiting HLA-B27 homodimer- driven immune cell inflammation in spondylarthritis.Arthritis Rheum. 64, 3139-3149.
34. Pende, D., Biassoni, R., Cantoni, C., Verdiani, S., Falco, M., di Donato, C., et al. (1996). The natural killer cell receptor specific for HLA-A allotypes: a novel member of the p58/p70 family of inhibitory recep- tors that is characterized by three immunoglobulin-likedomainsandis expressed as a 140-kD disulphide- linked dimer. J. Exp. Med. 184, 505-518.
35. Poszepczynska-Guigne, E., Schiavon, V., D'Incan, M., Echchakir, H., Musette,P.,Ortonne,N.,et al.(2004). CD158k/KIR3DL2 is a new pheno- typicmarkerofSezarycells:relevance for the diagnosis and follow-up of Sezary syndrome. J. Invest. Dermatol. 122,820-823.
36. Raffeiner, B., Dejaco, C., Duftner, C., Kullich, W., Goldberger, C., Vega, S. C., et al. (2005). Between adap- tive and innate immunity: TLR4- mediated perforin production by CD28null T-helper cells in ankylos- ing spondylitis. Arthritis Res. Ther. 7, R1412-R1420.
37. Raine, T., Brown, D., Bowness, P., Hill Gaston, J. S., Moffett, A., Trows- dale, J., et al. (2006). Consistent patterns of expression of HLA class I free heavy chains in healthy indi- viduals and raised expression in spondyloarthropathy patients point to physiological and pathological roles. Rheumatology (Oxford) 45, 1338-1344.
38. Reveille, J. D., Sims, A. M., Danoy, P., Evans, D. M., Leo, P., Pointon, J. J., et al. (2011). Genome-wide associ- ation study of ankylosing spondyli- tis identifies non-MHC susceptibility loci. Nat. Genet. 43,761-767.
39. Santourlidis, S., Graffmann, N., Christ, J., and Uhrberg, M. (2008). Lineage- specific transition of histone signa- tures in the killer cell Ig-like receptor locus from hematopoietic progeni- torto NK cells.J. Immunol. 180, 418-425.
40. Sheikh, S. Z., Matsuoka, K., Kobayashi, T., Li, F., Rubinas, T., and Plevy, S. E. (2010). Cutting edge: IFN- gamma is a negative regulator of IL-23 in murine macrophages and experimentalcolitis. J.Immunol. 184, 4069-4073.
41. Shen, H., Goodall, J.C., and HillGaston, J. S. (2009). Frequency and pheno- type of peripheral blood Th17 cells in ankylosing spondylitis and rheuma- toid arthritis. Arthritis Rheum. 60, 1647-1656.
42. Sivori, S., Falco, M., Carlomagno, S., Romeo, E., Soldani, C.,Bensussan, A., et al. (2010). A novel KIR-associated function: evidence that CpG DNA uptake and shuttling to early endo- somes is mediated by KIR3DL2. Blood 116, 1637-1647.
43. Trowsdale, J., Barten, R., Haude, A., Stewart, C. A., Beck, S., and Wilson, M. J. (2001). The genomic context of natural killer receptor extended gene families. Immunol. Rev. 181, 20-38.
44. Tsai, W. C., Chen, C. J., Yen, J. H., Ou, T. T., Tsai, J. J., Liu, C. S., et al. (2002). Free HLA class I heavy chain-carrying monocytes - a potential role in the pathogenesis of spondyloarthropathies. J.Rheumatol. 29,966-972.
45. van Bergen, J., Thompson, A., van der Slik, A., Ottenhoff, T. H., Gussekloo, J., and Koning, F. (2004). Pheno- typic and functional characterization of CD4T cells expressing killer Ig-like receptors. J. Immunol. 173, 6719-6726.
46. van der Fits, L., Out-Luiting, J. J., van Leeuwen, M. A., Samsom, J. N., Willemze, R., Tensen, C. P., et al. (2012). Autocrine IL-21 stimulation is involved in the maintenance of con- stitutive STAT3 activation in Sezary Syndrome. J. Investig. Dermatol. 132, 440-447
47. Vivian, J. P., Duncan, R. C., Berry, R., O'Connor, G. M., Reid, H. H., Beddoe, T., et al. (2011). Killer cell immunoglobulin- like receptor 3DL1-mediated recog- nition of human leukocyt eantigen B. Nature 479,401-405.
48. Wagtmann,N.,Biassoni,R.,Cantoni,C., Verdiani,S.,Malnati,M.S.,Vitale,M., et al. (1995). Molecular clones of the p58 NK cell receptor reveal immuno- globulin-related molecules with dive- rsity in both the extra- and intracel- lular domains. Immunity 2,439-449.
49. Warrington, K. J., Takemura, S., Goronzy, J. J., and Weyand, C. M. (2001). CD4+, CD28- T cells in rheumatoid arthritis patients com- bine features of the innate and adaptive immune systems. Arthritis Rheum. 44, 13-20.
50. Wendling, D., Cedoz, J.-P., Racadot, E., and Dumoulin, G. (2007). Serum IL-17, BMP-7, and bone turnover markers in patients with ankylos- ing spondylitis. Joint Bone Spine 74, 304-305.
51. Zhang, L., Dai, Y., Wang, L., Peng, W., Zhang, Y., Ou, Y., et al. (2011). CpG array analysis of histone H3 lysine 4 trimethylation in periph- eral blood mononuclear cells of uremia patients. DNA Cell Biol. 30, 179-186.